FDA Is Going After Kratom, Warning Companies to Stop Selling It for Opioid Addiction and Cancer
By Ed Cara
The Food and Drug Administration is still pressing down hard on kratom—the plant treatment that adherents say has helped them manage their opioid addiction or chronic pain. This week, the agency announced it was sending warning letters to two online marketers and distributors, accusing them of illegally selling kratom products with false or unproven claims about their health benefits.
Comments
Post a Comment